Skip to main content

cancer Archives

Cell changes en route to stomach cancer

Sep. 26, 2013—Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer.

Read more


Live Facebook chat on hereditary cancer risk

Sep. 20, 2013—Join an upcoming live Facebook Chat in which Vanderbilt-Ingram Cancer Center experts will answer your questions about hereditary cancer risk on Sept. 24 at 6 p.m.

Read more


VU study brings genome’s ‘dark matter’ into light

Sep. 19, 2013—Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer.

Read more


Fishing for new anti-cancer drugs

Sep. 18, 2013—Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

Read more


Cancer nanomedicines on target

Sep. 13, 2013—Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.

Read more


VU study identifies DNA changes in drug-resistant cancer cells

Sep. 12, 2013—Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.

Read more


Motor protein revs up cell division

Jul. 29, 2013—A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.

Read more


Factor’s yin-yang tumor effects

Jun. 10, 2013—A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.

Read more


Leukemia & Lymphoma Society honors Ohi’s research

Jun. 6, 2013—Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma.

Read more


West Tennessee Healthcare and Vanderbilt University Medical Center announce academic affiliation agreement

May. 21, 2013—Leaders of West Tennessee Healthcare (WTH) and Vanderbilt University Medical Center today announced an academic affiliation agreement which further establishes a collaborative relationship between the two institutions, now for the creation of new cancer programs in West Tennessee. The new agreement creates a framework for the future development of cooperative programs between Vanderbilt-Ingram Cancer Center...

Read more


Cancer studies reveal new genetic variants

Apr. 4, 2013—The future of cancer is becoming clearer. And it’s not looking so good for cancer.

Read more


Fingers and toes: joint forming factor

Apr. 1, 2013—The gene Has2 participates in signaling that is important in developing fingers and toes, and may have relevance for cancer development.

Read more


Recent Stories from VUMC News and Communications Publications

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer.  Don’t hesitate. Do it.

Momentum

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer. Don’t hesitate. Do it.

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

more